Search Results
Combination pembrolizumab and reduced-dose ipilimumab: how low can you go?
Atkins: Pembrolizumab, Ipilimumab for Melanoma, RCC
Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology
KEYNOTE-029: pembrolizumab with ipilimumab for melanoma
Dosing regiment in the combination of ipilimumab and nivolumab in stage III melanoma
Pembrolizumab is better than ipilimumab for advanced melanoma in phase III trial
Novel triple combination therapies for melanoma
Ipilimumab Alone or In Combination w Anti-PD-1 Therapy in Pts w Melanoma Resistant to Anti-PD1 Mono
KEYNOTE-006: the efficacy of ipilimumab after pembrolizumab in patients with advanced melanoma
Safety and efficacy of increased ipilimumab dosage in metastatic melanoma
Krista Rubin on Understanding Ipilimumab's Toxicities
Dr. Wolchok on Weighing Risk and Benefit of Nivolumab/Ipilimumab Combo in Melanoma
